pipette
ESEspañol

Transient receptor potential channel activation targets multiple stages of the schistosome parasite

Shashank Kulkarni, Sang-Kyu Park, Youssef Hamway, Lukas Friedrich, Jesko Kaiser, Evgeny G. Chulkov, Claudia M. Rohr, Cécile Häberli, Martin Horn, Tobias Hyun Ho Baeurle, Mario Pellegatti, Gary Grosser, Axel Becker, Rana Afshar, Andreas D. Becker, Nico Alexander Mell, Floriane Lignet, Philip G. Hewitt, Annika Hansen, Christian Brenneis, Jan Dvořák, Clarissa Prazeres da Costa, Jennifer Keiser, Jonathan S. Marchant, Thomas Spangenberg

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Here, we describe a drug candidate, M5493, with potent activity against multiple parasite life cycle stages.
Limitation the authors admit
To circumvent its limited bioavailability, the active agent was converted to prodrug M5493, which displayed robust activity against the schistosome parasite at doses as low as 5 milligrams per kilogram in mice infected with Schistosoma mansoni .

Appeared: Friday, October 9. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aed8353